Cost of Respiratory Syncytial Virus Infections in US Infants: Systematic Literature Review and Analysis.
Diana M BowserKatharine R RowlandsDhwani HariharanRaíssa M GervasioLauren BuckleyYara Halasa-RappelElizabeth L GlaserChristopher B NelsonDonald S ShepardPublished in: The Journal of infectious diseases (2022)
Public sources pay for more than half of infants' RSV medical costs, constituting the highest rate of RSVHs and the highest expenditure per birth. Full-term infants are the predominant source of infant RSVHs and costs.